Compounds for the treatment of metabolic disorders
Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed.
1. A process for producing a compound of the formula:
wherein R 6 is alkyl having from 1 to 7 carbon atoms; n is 1 or 2; t is 0 or 1; and
A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from: halo, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or
cycloalkyl having from 3 to 6 ring carbon atoms wherein the cycloalkyl is unsubstituted or one or two ring carbons are independently mono-substituted by methyl or ethyl; or
a 5 or 6 membered heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S and O and the heteroaromatic ring is covalently bound to the remainder of the compound by a ring carbon,
comprising, reacting a compound of the formula:
with a compound of the formula BrCH 2 CO 2 R 6 in the presence of a base, wherein R 6 , n, t and A are as above, to yield the corresponding compound of formula XI.
2. The process of claim 1 , further comprising hydrolyzing the compound of formula XI to remove R 6 and yield the corresponding acid.
3. A process for producing a compound of the formula:
wherein R 5 is alkyl having from 1 to 3 carbon atoms; R 6 is alkyl having from 1 to 7 carbon atoms; n is 1 or 2; t is 0 or 1; and
A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from: halo, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or
cycloalkyl having from 3 to 6 ring carbon atoms wherein the cycloalkyl is unsubstituted or one or two ring carbons are independently mono-substituted by methyl or ethyl; or
a 5 or 6 membered heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S and O and the heteroaromatic ring is covalently bound to the remainder of the compound by a ring carbon,
comprising, reacting a compound of the formula:
with a compound of the formula BrCH 2 CO 2 R 6 in the presence of an alkali metal silyl amide, wherein R 6 , n, t and A are as above, to yield the corresponding compound of formula XXV.
4. The process of claim 3 , further comprising hydrolyzing the compound of formula XXV to remove R 6 and yield the corresponding acid.
5. A process for producing a compound of the formula:
wherein n is 1 or 2; t is 0 or 1; and
A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from: halo, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or
cycloalkyl having from 3 to 6 ring carbon atoms wherein the cycloalkyl is unsubstituted or one or two ring carbons are independently mono-substituted by methyl or ethyl; or
a 5 or 6 membered heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S and O and the heteroaromatic ring is covalently bound to the remainder of the compound by a ring carbon,
comprising, reacting a compound of the formula:
with the sodium salt of diethylacetamidomalonate, wherein n, t and A are as above, to yield the corresponding compound of formula XXVIII.